Cantitate/Preț
Produs

Hormone Receptors in Breast Cancer: Cancer Treatment and Research, cartea 147

Editat de Suzanne A. W. Fuqua
en Limba Engleză Paperback – 20 oct 2014
Hormone Receptors in Breast Cancer provides an up-to-date resource of the role of hormone receptors in breast cancer written in depth for both the basic molecular academic researcher and translational scientist. Advances in basic science of molecular endocrinology have undoubtedly been translated into clinical practice, and clinicians caring for this disease need to be knowledgeable about these developments. The molecular basis of hormone action has been elucidated, and the relative significance of the different estrogen and progesterone receptor isoforms has been explored. This explosion of information has lead to exciting new areas of gene specific targeting of the disease, and breast cancer prevention. Paradigm shifts in treatment options and sequencing have recently occurred in breast cancer management, necessitating close cooperation and communication between translational scientists and physicians. This book is focused on providing this communication.
Citește tot Restrânge

Toate formatele și edițiile

Toate formatele și edițiile Preț Express
Paperback (1) 74921 lei  6-8 săpt.
  Springer Us – 20 oct 2014 74921 lei  6-8 săpt.
Hardback (1) 98284 lei  39-44 zile
  Springer Us – 2 dec 2008 98284 lei  39-44 zile

Din seria Cancer Treatment and Research

Preț: 74921 lei

Preț vechi: 78863 lei
-5% Nou

Puncte Express: 1124

Preț estimativ în valută:
14339 15127$ 11949£

Carte tipărită la comandă

Livrare economică 02-16 ianuarie 25

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9781489996800
ISBN-10: 148999680X
Pagini: 292
Ilustrații: X, 281 p.
Dimensiuni: 155 x 235 x 15 mm
Greutate: 0.41 kg
Ediția:2009
Editura: Springer Us
Colecția Springer
Seria Cancer Treatment and Research

Locul publicării:New York, NY, United States

Public țintă

Professional/practitioner

Cuprins

Hormone Action and Clinical Significance of the Estrogen Receptor #x03B1;.- Role of ER#x03B2; in Clinical Breast Cancer.- Hormone Action and Breast Cancer.- Estrogen Receptors in Breast Tumors of African American Patients.- BRCA1 Cross-Talk with Hormone Receptors.- Metastasis of Hormone Receptor Positive Breast Cancer.- Endocrine Therapy with Selective Estrogen Receptor Modulators (SERMs) and Aromatase Inhibitors in the Prevention and Adjuvant Therapy Settings.- Biomarkers in Neoadjuvant Trials.- Hormone Resistance.- Strategies of Hormonal Prevention.- Estrogen Receptor Phenotypes Defined by Gene Expression Profiling.

Textul de pe ultima copertă

This book provides an up-to-date resource of the role of hormone receptors in breast cancer written in depth for both the basic molecular academic researcher and translational scientist. Advances in basic science of molecular endocrinology have undoubtedly been translated into clinical practice, and clinicians caring for this disease need to be knowledgeable about these developments. The molecular basis of hormone action has been elucidated, and the relative significance of the different estrogen and progesterone receptor isoforms has been explored. This explosion of information has led to exciting new areas of gene specific targeting of the disease, and breast cancer prevention. Paradigm shifts in treatment options and sequencing have recently occurred in breast cancer management, necessitating close cooperation and communication between translational scientists and physicians. Hormone Receptors in Breast Cancer focuses on providing this communication.
"Hormones play an essential role in both the development of breast cancer and its therapy. This text provides a comprehensive review of the key receptors and signaling pathways that effect breast cancer growth leading figures in the field provide insight into the basic biology and clinical issues relevant to this devastating disease."
Steven T. Rosen, MD, Series Editor

Caracteristici

The book will be of value as a significant resource for the practicing clinician keeping abreast of the most current targeted and combination hormone therapies for breast cancer managment and prevention strategies.